Mechanisms of tumor necrosis factor-alpha-induced leaks in intestine epithelial barrier

Cytokine. 2012 Aug;59(2):264-72. doi: 10.1016/j.cyto.2012.04.008. Epub 2012 May 12.

Abstract

Purpose: The aim of this study was to investigate the signaling mechanisms surrounding changes in tight junction (TJ) and the permeability of human intestinal epithelial cell induced by tumor necrosis factor-alpha (TNF-α).

Methods: To confirm that TNF-α induces epithelial barrier hyperpermeability by disrupting tight junction, Caco-2 cells were exposed to TNF-α, and changes in epithelial permeability (via TER assay), F-actin dynamics (via Rhodamine-phalloidin staining) and tight junction protein expression (via western blot) were monitored. Moreover, to ensure that NF-κB participated in the regulatory mechanisms, Caco-2 cells were transfected with DNMu-IκBα or control plasmids, the above experiments were repeated and the activation effect of TNF-α on NF-κB was detected by luciferase reporter assays. Lastly, we took dominant negative plasmid and knockdown approaches to investigate the potential importance of the NF-κB/myosin light chain kinase (MLCK)/myosin light chain phosphorylation (pMLC) pathways in TNF-a-mediated damage.

Result: TNF-α could cause NF-κB activation, F-actin rearrangement, tight junction disruption and barrier dysfunction. These effects were alleviated by inhibiting NF-κB. TNF-α induced increase of MLCK transcription and MLC phosphorylation act later than NF-κB activation, which could be suppressed both by inactivating and deleting NF-κB.

Conclusions: TNF-α induces intestinal epithelial cell hyperpermeability by disrupting TJs, in part through MLCK upregulation, in which NF-κB is the positive upstream regulator for MLCK.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism
  • Caco-2 Cells
  • Cell Membrane Permeability / drug effects
  • Epithelium / drug effects*
  • Epithelium / metabolism
  • Epithelium / pathology*
  • Humans
  • I-kappa B Proteins / metabolism
  • Intestinal Mucosa / metabolism
  • Intestines / drug effects*
  • Intestines / pathology*
  • Myosin Light Chains / metabolism
  • Myosin-Light-Chain Kinase / genetics
  • Myosin-Light-Chain Kinase / metabolism
  • NF-KappaB Inhibitor alpha
  • NF-kappa B / metabolism
  • Phosphorylation / drug effects
  • Plasmids / metabolism
  • RNA, Small Interfering / metabolism
  • Tight Junctions / drug effects
  • Tight Junctions / metabolism
  • Transcription Factor RelA / metabolism
  • Transcription, Genetic / drug effects
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Actins
  • I-kappa B Proteins
  • Myosin Light Chains
  • NF-kappa B
  • NFKBIA protein, human
  • RNA, Small Interfering
  • Transcription Factor RelA
  • Tumor Necrosis Factor-alpha
  • NF-KappaB Inhibitor alpha
  • Myosin-Light-Chain Kinase